February 26, 2010
Section : Mental Health Info

Becoming a caregiver is not an easy task for family and friends of a loved one with Alzheimer's Disease.

February 18, 2025
Section : Patient care

Since its creation in 1986, the Eating Disorders Program (EDP) has offered specialized clinical services for people 18 years and older who suffer from anorexia nervosa or bulimia nervosa.

February 18, 2025
Section : Patient care

The Clinic for Assessment of Youth at Risk (CAYR) is a sub-program of PEPP-Montréal and accepts youth between 14 and 30 years of age who have never experienced a psychotic episode but who show signs of increased risk for developing psychosis.

April 22, 2010
Section : Patient care

Treating psychosis involves education, counselling, medication, close monitoring of symptoms, stress management, and a strong, supportive environment.

April 22, 2010
Section : Patient care

The Prevention and Early Intervention Program for Psychosis (PEPP-Montréal) is a program for young people who are experiencing an untreated first episode of psychosis.

April 20, 2010
Section : Patient care

The Bipolar Disorders Program is a superspecialized (third-line) consultation and treatment service for adults aged 18 to 65 who suffer from refractory bipolar disorders.

February 18, 2025
Section : Patient care

The Program for Dementia with Psychiatric Comorbidity (PDCP) provides superspecialized care to people of all ages who have mild to severe cognitive impairments combined with psychiatric or behavioural disorders.

February 18, 2025
Section : Mental Health Info

Classes are held every Tuesdays at 7 PM, from October 23 to November 27, 2007. They were overseen by Hani Iskandar, MD, Clinical Chief at Psychiatric Intensive Care Unit and Coordinator in Undergraduate Medical Education at Douglas I

April 23, 2010
Section : The Douglas

Douglas Hospital was founded in 1881 by Alfred Perry and a group of Protestant clergy and Montréal citizens.

March 22, 2013
Section : Research

Her current research interests lie in the areas of molecular genetic and personality factors that influence eating disorder symptoms and treatment outcomes.